Use of Finasteride and Spironolactone in Hospitalized COVID-19 Patients and Their Effect on Severity Outcomes

    May 2023
    F. Loyola-Nieto, C.M. Ramirez, M. Ziad-M. Said … J. Varon
    Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer

    We don't know much about this study yet.

    Read the full study on atsjournals.org →
    Discuss this study in the Community →

    Related research 1

    1. Topical Finasteride Versus Topical Spironolactone in the Treatment of Androgenetic Alopecia The Medical Journal of Cairo University · 2020